Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)
| Autor: | Jan Bakker, Robert Grover, Angela McLuckie, Laurent Holzapfel, Jan Andersson, Robert Lodato, David Watson, Steven Grossman, Jill Donaldson, Jukka Takala, on behalf of the Glaxo Wellcome International Septic Shock Study Group |
|---|---|
| Zdroj: | Critical Care Medicine; Jan2004, Vol. 32 Issue 1, p1-12, 12p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|